WHO ICTRP trial
Bioequivalence Study of 6-Mercaptopurine in Adult patients with Acute…
CTRI/2010/091/000328 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2010/091/000328 |
|---|---|
| Public title | Bioequivalence Study of 6-Mercaptopurine in Adult patients with Acute Lymphoblastic Leukemia. |
| Scientific title | An Open Label, Balanced, Randomized, Multicentre, Single-Dose, Three-Period, Two-Treatment, Three-Sequence, Crossover Comparative Bioequivalence Study of Two Formulations of 6-Mercaptopurine in Adult patients with Acute Lymphoblastic Leukemia (ALL) under fasting condition. - Nill |
| Primary sponsor | Orion Pharma |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | BA/BE |
| Countries | India;India |
| Conditions | Health Condition 1: null- Acute Lymphoblastic Leukemia (ALL) |
| Interventions | Intervention1: Mercaptopurine 50 mg tablet, Orion Pharma: A single oral dose (multiples of 50 mg) will be administered as per randomization schedule in each period with approximately 240 mL of water at ambient temperature in sitting… |
| Registration date | Dec 31, 2010 |
| Target size | 39 |
| Secondary IDs | ARL/CT/09/003 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: